In November, London’s gender youth clinic, run by the National Health Service, was forced to stop administering puberty-blocking drugs to children under the age of 16. Newly published short-term outcomes research suggests that the effects of puberty blockers, specifically in relation to bone-mass density and height, are not as “fully reversible” as the clinic once promised.